Skip to main content

Table 1 Patient characteristics of controls, POA/OPOI and DOR patients

From: Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women?

  POA/OPOI DOR Controls P value (Sidak test)
N 135 155 32  
Age (years) 34.5 ± 3.21,2 43.2 ± 2.41,3 33.1 ± 3.72,3 10.001, 20.04, 30.001
BMI (kg/m2) 24.0 ± 4.8 24.3 ± 5.0 22.0 ± 5.5  
FSH (mIU/mL) 13.4 ± 14.24,5 17.8 ± 13.14,6 6.3 ± 2.55,6 40.02, 50.02, 60.001
AMH (ng/mL) 0.9 ± 1.17,8 0.3 ± 0.37,9 3.3 ± 2.18,9 70.001, 80.001, 90.001
Race n (%)     
Caucasian 90 (66.7) 119 (76.8) 19 (59.4)  
African 16 (11.9) 18 (11.6) 4 (12.5)  
Asian 29 (21.5) 18 (11.6) 9 (28.1)  
  1. Values are presented as means ± SD.